{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T13:26:52Z","timestamp":1768742812958,"version":"3.49.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T00:00:00Z","timestamp":1529366400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s00280-018-3625-5","type":"journal-article","created":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T02:58:44Z","timestamp":1529377124000},"page":"361-365","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Therapeutic drug monitoring and dose adaptation of cisplatin in a newborn with hepatoblastoma: a case report"],"prefix":"10.1007","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9886-412X","authenticated-orcid":false,"given":"Fabienne","family":"Thomas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1897-8678","authenticated-orcid":false,"given":"Gareth J.","family":"Veal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9743-5603","authenticated-orcid":false,"given":"Souleiman","family":"El Balkhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Lafont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8460-903X","authenticated-orcid":false,"given":"Nicolas","family":"Picard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7798-6651","authenticated-orcid":false,"given":"Laurence","family":"Brugi\u00e8res","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7740-9096","authenticated-orcid":false,"given":"Etienne","family":"Chatelut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Piguet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,19]]},"reference":[{"key":"3625_CR1","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S1470-2045(16)30598-8","volume":"18","author":"RL Meyers","year":"2017","unstructured":"Meyers RL, Maibach R, Hiyama E et al (2017) Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children\u2019s Hepatic tumors International Collaboration. Lancet Oncol 18:122\u2013131","journal-title":"Lancet Oncol"},{"key":"3625_CR2","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S1089-3261(05)70163-X","volume":"5","author":"JT Stocker","year":"2001","unstructured":"Stocker JT (2001) Hepatic tumors in children. Clin Liver Dis 5:259\u2013281 (viii\u2013ix)","journal-title":"Clin Liver Dis"},{"key":"3625_CR3","doi-asserted-by":"crossref","unstructured":"Dall\u2019Igna P, Brugieres L, Christin AS et al (2018) Hepatoblastoma in children aged less than six months at diagnosis: a report from the SIOPEL group. Pediatr Blood Cancer 65. \n                    https:\/\/www-ncbi-nlm-nih-gov.gate2.inist.fr\/pubmed\/28921839","DOI":"10.1002\/pbc.26791"},{"key":"3625_CR4","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/S1470-2045(13)70272-9","volume":"14","author":"J Zsiros","year":"2013","unstructured":"Zsiros J, Brugieres L, Brock P et al (2013) Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study. Lancet Oncol 14:834\u2013842","journal-title":"Lancet Oncol"},{"key":"3625_CR5","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1016\/j.ejca.2015.07.011","volume":"51","author":"GJ Veal","year":"2015","unstructured":"Veal GJ, Errington J, Hayden J et al (2015) Carboplatin therapeutic monitoring in preterm and full-term neonates. Eur J Cancer 51:2022\u20132030","journal-title":"Eur J Cancer"},{"key":"3625_CR6","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s00280-016-2975-0","volume":"77","author":"GJ Veal","year":"2016","unstructured":"Veal GJ, Errington J, Sastry J et al (2016) Adaptive dosing of anticancer drugs in neonates: facilitating evidence-based dosing regimens. Cancer Chemother Pharmacol 77:685\u2013692","journal-title":"Cancer Chemother Pharmacol"},{"key":"3625_CR7","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1056\/NEJMoa0810613","volume":"361","author":"G Perilongo","year":"2009","unstructured":"Perilongo G, Maibach R, Shafford E et al (2009) Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma. N Engl J Med 361:1662\u20131670","journal-title":"N Engl J Med"},{"key":"3625_CR8","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/0006-2944(77)90089-8","volume":"18","author":"AF LeRoy","year":"1977","unstructured":"LeRoy AF, Wehling ML, Sponseller HL et al (1977) Analysis of platinum in biological materials by flameless atomic absorption spectrophotometry. Biochem Med 18:184\u2013191","journal-title":"Biochem Med"},{"key":"3625_CR9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.drup.2010.12.002","volume":"14","author":"H Burger","year":"2011","unstructured":"Burger H, Loos WJ, Eechoute K et al (2011) Drug transporters of platinum-based anticancer agents and their clinical significance. Drug Resist Updat 14:22\u201334","journal-title":"Drug Resist Updat"},{"key":"3625_CR10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1124\/mol.110.070680","volume":"80","author":"DE Sweeney","year":"2011","unstructured":"Sweeney DE, Vallon V, Rieg T et al (2011) Functional maturation of drug transporters in the developing, neonatal, and postnatal kidney. Mol Pharmacol 80:147\u2013154","journal-title":"Mol Pharmacol"},{"key":"3625_CR11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.lfs.2008.05.004","volume":"83","author":"AJ Lickteig","year":"2008","unstructured":"Lickteig AJ, Cheng X, Augustine LM et al (2008) Tissue distribution, ontogeny and induction of the transporters Multidrug and toxin extrusion (MATE) 1 and MATE2 mRNA expression levels in mice. Life Sci 83:59\u201364","journal-title":"Life Sci"},{"key":"3625_CR12","first-page":"2005","volume":"50","author":"C Bardin","year":"2014","unstructured":"Bardin C, Veal G, Paci A et al (2014) Therapeutic drug monitoring in cancer\u2014are we missing a trick? Eur J Cancer Oxf Engl 1990 50:2005\u20132009","journal-title":"Eur J Cancer Oxf Engl 1990"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-018-3625-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-018-3625-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-018-3625-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T19:18:22Z","timestamp":1560885502000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-018-3625-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,19]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["3625"],"URL":"https:\/\/doi.org\/10.1007\/s00280-018-3625-5","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,19]]},"assertion":[{"value":"19 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from the parents of the patient to take blood samples to perform individualized dosing.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}